Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001736730-25-000070
Filing Date
2025-08-14
Accepted
2025-08-14 16:19:36
Documents
75
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q camp-20250630.htm   iXBRL 10-Q 888460
2 EX-19.1 exhibit191-amendedandresta.htm EX-19.1 53136
3 EX-31.1 camp-20250331x10qexx3111.htm EX-31.1 10834
4 EX-31.2 camp-20250331x10qexx3121.htm EX-31.2 10950
5 EX-32.1 camp-20250331x10qexx3211.htm EX-32.1 5545
6 EX-32.2 camp-20250331x10qexx3221.htm EX-32.2 5550
12 camp-20250630_g1.jpg GRAPHIC 9296
  Complete submission text file 0001736730-25-000070.txt   5633513

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250630.xsd EX-101.SCH 46731
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT camp-20250630_cal.xml EX-101.CAL 64010
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT camp-20250630_def.xml EX-101.DEF 165132
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20250630_lab.xml EX-101.LAB 570135
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20250630_pre.xml EX-101.PRE 398483
78 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250630_htm.xml XML 661904
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42365 | Film No.: 251219537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)